EDITOR’S NOTE: Each month, we invite a long list of companies to participate in the Tech Guide. There’s no quid pro quo—this is editorial, not an advertising section—all vendors are welcome. I invite you to suggest vendors.—Judy O’Rourke, [email protected], 619-659-1065.

CLP08 TechGuide-1CLP‘s August 2013 TECH GUIDE, on the topic of molecular testing, is available as a downloadable pdf – you will need Adobe Acrobat reader to view it.

If you do not have Adobe Acrobat on your computer, you can download it for free from Adobe.

Space in print was limited this month, so we’re sharing some additional product information below:

eSensor XT-8 system from GenMark, Carlsbad, Calif, is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. GenMark currently markets four tests that are FDA-cleared for IVD use, including Thrombophilia Risk Test and Warfarin Sensitivity Test.
GenMark Diagnostics
(760) 448-4300; www.genmarkdx.com

The Breast Cancer Index from bioTheranostics, San Diego, is a gene expression-based biomarker for patients with estrogen receptor-positive, Stage I and IIA-lymph node-negative breast cancer. It provides quantitative assessment of the likelihood of overall (0-10 years), early (0-5 years), and late (post-5 years) recurrence, and prediction of benefit from extended endocrine therapy in patients who are recurrence-free after 5-years of adjuvant endocrine therapy.
(877) 886-6739; www.biotheranostics.com

The illumigene C. difficile test from Meridian Bioscience Inc, Cincinnati, is a clinically definitive assay for C. difficile testing. It complies fully with ASM guidelines and provides accurate results with one test, one specimen. illumigene C. difficile can help reduce health care costs associated with isolation, antibiotics, and outbreaks.
Meridian Bioscience
(513) 271-3700; www.meridianbioscience.com

illumigene GBS from Meridian Bioscience Inc, Cincinnati, is an assay for Group B Streptococcus detection. It allows for appropriate treatment of mother at time of delivery, ensuring best outcome for baby. The simplified procedure allows labs to report accurate, definitive results in less time than culture.
Meridian Bioscience
(513) 271-3700; www.meridianbioscience.com